Karyopharm targets $1B revenue potential for Selinexor in myelofibrosis amid Phase 3 progress
Q4 2024 Management View Richard Paulson, President and CEO, highlighted the company's achievements in 2024, including meeting financial guidance, executing cost reduction initiatives, and advancing ...
Healthcare Dive29m
FTC retains stricter merger guidelines under Trump
FTC Chair Andrew Ferguson sent a memo to agency staff on Tuesday clarifying that the Biden-era guidelines will remain in ...